Chun‐Sheng Yang

1.2k total citations
33 papers, 727 citations indexed

About

Chun‐Sheng Yang is a scholar working on Neurology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Chun‐Sheng Yang has authored 33 papers receiving a total of 727 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Neurology, 18 papers in Pathology and Forensic Medicine and 8 papers in Molecular Biology. Recurrent topics in Chun‐Sheng Yang's work include Multiple Sclerosis Research Studies (17 papers), Peripheral Neuropathies and Disorders (15 papers) and Myasthenia Gravis and Thymoma (7 papers). Chun‐Sheng Yang is often cited by papers focused on Multiple Sclerosis Research Studies (17 papers), Peripheral Neuropathies and Disorders (15 papers) and Myasthenia Gravis and Thymoma (7 papers). Chun‐Sheng Yang collaborates with scholars based in China, United States and United Kingdom. Chun‐Sheng Yang's co-authors include Fu‐Dong Shi, Li Yang, Xinghu Zhang, Dongmei Jia, Chao Zhang, Wei Qiu, Meini Zhang, Li Yang, Chunshui Yu and Jing Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and The Lancet Neurology.

In The Last Decade

Chun‐Sheng Yang

32 papers receiving 719 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chun‐Sheng Yang China 14 401 354 125 111 99 33 727
A. Dimitrakopoulos Greece 14 183 0.5× 113 0.3× 113 0.9× 134 1.2× 139 1.4× 30 658
Lynn Stazzone United States 9 152 0.4× 431 1.2× 81 0.6× 28 0.3× 82 0.8× 10 530
Yinan Zhang United States 13 106 0.3× 209 0.6× 131 1.0× 63 0.6× 113 1.1× 29 629
Yusuke Terada Japan 7 241 0.6× 277 0.8× 71 0.6× 31 0.3× 44 0.4× 16 417
T. Arbizu Spain 15 216 0.5× 563 1.6× 154 1.2× 38 0.3× 118 1.2× 28 745
Larisa Miller United States 7 137 0.3× 175 0.5× 127 1.0× 13 0.1× 76 0.8× 11 427
Smriti Agrawal India 10 54 0.1× 84 0.2× 157 1.3× 112 1.0× 197 2.0× 38 606
Hongyang Zhao China 16 203 0.5× 59 0.2× 74 0.6× 42 0.4× 376 3.8× 54 877
Liza Rijvers Netherlands 10 49 0.1× 162 0.5× 200 1.6× 60 0.5× 70 0.7× 13 461
P. Petiot France 13 509 1.3× 33 0.1× 39 0.3× 24 0.2× 111 1.1× 50 788

Countries citing papers authored by Chun‐Sheng Yang

Since Specialization
Citations

This map shows the geographic impact of Chun‐Sheng Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chun‐Sheng Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chun‐Sheng Yang more than expected).

Fields of papers citing papers by Chun‐Sheng Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chun‐Sheng Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chun‐Sheng Yang. The network helps show where Chun‐Sheng Yang may publish in the future.

Co-authorship network of co-authors of Chun‐Sheng Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Chun‐Sheng Yang. A scholar is included among the top collaborators of Chun‐Sheng Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chun‐Sheng Yang. Chun‐Sheng Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Xiaoyu, Lijie Zhu, Zhirui Liu, et al.. (2025). Single‐cell atlas reveals heterogeneous response to FcRn blockade in anti‐AChR antibody‐positive generalised myasthenia gravis. Clinical and Translational Medicine. 15(8). e70436–e70436. 2 indexed citations
2.
Gold, Ralf, Michael Barnett, Andrew Chan, et al.. (2023). Clinical use of dimethyl fumarate in multiple sclerosis treatment: an update to include China, using a modified Delphi method. Therapeutic Advances in Neurological Disorders. 16. 4223461822–4223461822. 2 indexed citations
3.
Zeng, Zheng, et al.. (2022). Efficacy of mycophenolate mofetil for AQP4 antibody positive optic neuritis immunotherapy. SHILAP Revista de lepidopterología. 1 indexed citations
4.
Li, Yue, Nan Wang, Ming Yi, et al.. (2021). Efficacy and safety of different dosages of rituximab for refractory generalized AChR myasthenia gravis: A meta-analysis. Journal of Clinical Neuroscience. 85. 6–12. 18 indexed citations
5.
Kong, Ying, Handong Li, Dan Wang, et al.. (2021). Group 2 innate lymphoid cells suppress the pathology of neuromyelitis optica spectrum disorder. The FASEB Journal. 35(11). e21856–e21856. 6 indexed citations
6.
Li, Ting, He Li, Yue Li, et al.. (2021). Multi-Level Analyses of Genome-Wide Association Study to Reveal Significant Risk Genes and Pathways in Neuromyelitis Optica Spectrum Disorder. Frontiers in Genetics. 12. 690537–690537. 7 indexed citations
7.
8.
Wang, Nan, Mingqi Liu, Shumin Jiang, et al.. (2020). Cerebrospinal fluid lactate level in aquaporin-4 antibody positive neuromyelitis optica spectrum disorders: a hint on differential diagnosis and possible immunopathogenesis. Multiple Sclerosis and Related Disorders. 47. 102629–102629. 1 indexed citations
9.
Fan, Moli, Wei Qiu, Bitao Bu, et al.. (2020). Risk of COVID-19 infection in MS and neuromyelitis optica spectrum disorders. Neurology Neuroimmunology & Neuroinflammation. 7(5). 64 indexed citations
10.
Xu, Lu, Linjie Zhang, Li Yang, et al.. (2020). Positive association of herpes simplex virus-IgG with multiple sclerosis: A systematic review and meta-analysis. Multiple Sclerosis and Related Disorders. 47. 102633–102633. 16 indexed citations
11.
Zheng, Kai, et al.. (2020). Association of Fibroblast Growth Factor 23 With Ischemic Stroke and Its Subtypes: A Mendelian Randomization Study. Frontiers in Genetics. 11. 608517–608517. 9 indexed citations
12.
Yang, Chun‐Sheng, Yu Deng, Lin‐Jie Zhang, et al.. (2019). Increased serum IL-36β and IL-36γ levels in patients with neuromyelitis optica spectrum disorders: association with disease activity. BMC Neurology. 19(1). 185–185. 9 indexed citations
13.
Yang, Chun‐Sheng, Ai Guo, Yulin Li, et al.. (2019). Dl-3-n-butylphthalide Reduces Neurovascular Inflammation and Ischemic Brain Injury in Mice. Aging and Disease. 10(5). 964–964. 56 indexed citations
14.
Yang, Chun‐Sheng, Lin‐Jie Zhang, Li Li, et al.. (2018). Neuromyelitis optica spectrum disorders with and without connective tissue disorders. BMC Neurology. 18(1). 177–177. 11 indexed citations
15.
Tian, De‐Cai, Chun‐Sheng Yang, Bin Han, et al.. (2017). Safety and Efficacy of Bortezomib in Patients With Highly Relapsing Neuromyelitis Optica Spectrum Disorder. JAMA Neurology. 74(8). 1010–1010. 55 indexed citations
16.
Zhang, Linjie, Qiuxia Zhang, Chun‐Sheng Yang, et al.. (2017). Anti-Rituximab antibody in patients with NMOSDs treated with low dose Rituximab. Journal of Neuroimmunology. 316. 107–111. 25 indexed citations
17.
Tang, Jianqin, Chun‐Sheng Yang, Yaxi Li, et al.. (2017). Recent developments in nanomedicine for melanoma treatment. International Journal of Cancer. 141(4). 646–653. 41 indexed citations
18.
Liang, Zhen, Chun‐Sheng Yang, Feng Gu, & Lansheng Zhang. (2017). A conditionally replicating adenovirus expressing IL-24 acts synergistically with temozolomide to enhance apoptosis in melanoma cells in vitro. Oncology Letters. 13(6). 4185–4189. 4 indexed citations
19.
Li, Yujing, Guoqiang Chang, Yuanchu Liu, et al.. (2015). Fingolimod alters inflammatory mediators and vascular permeability in intracerebral hemorrhage. Neuroscience Bulletin. 31(6). 755–762. 42 indexed citations
20.
Zhang, Fang, Yuan Qi, Guoqiang Chang, et al.. (2014). Association of circulating follicular helper T cells with disease course of NMO spectrum disorders. Journal of Neuroimmunology. 278. 239–246. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Dimitrakopoulos Breakdown of academic impact, for papers by Lynn Stazzone Breakdown of academic impact, for papers by Yinan Zhang Breakdown of academic impact, for papers by Yusuke Terada Breakdown of academic impact, for papers by T. Arbizu Breakdown of academic impact, for papers by Larisa Miller Breakdown of academic impact, for papers by Smriti Agrawal Breakdown of academic impact, for papers by Hongyang Zhao Breakdown of academic impact, for papers by Liza Rijvers Breakdown of academic impact, for papers by P. Petiot
Rankless by CCL
2026